AccessibilityHelpAbout Us
Health Advance logo

Health Advance(OTC) HADV

Market Cap$312.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)-99%
5 Year-100%
1 Year-33%
1 Month+0%
$0.00
+0.00%
+0.00Today
Health Advance last closing stock price
MetricPriceDate
Last closeUSD 0.002026-09-14
Health Advance stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-09-04
1 month+0%USD 0.002026-08-07
3 month+0%USD 0.002026-06-15
Year to date-33.33%USD 0.002025-12-31
1 year-33.33%USD 0.002025-09-12
3 year-95.65%USD 0.002023-09-12
5 year-99.67%USD 0.062021-09-15
Since inception-98.67%USD 0.022012-09-13

Health Advance Financials at a Glance

Market Cap

$312.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$87.21K

EPS (TTM)

-$0.00

P/E Ratio

-2.00

Dividend

$0.00

Beta (Volatility)

-0.01 (Low)

Price

$0.00

Volume

250,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

HADV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Health Advance

Health Advance Inc. is a development-stage company focused on providing a wide range of home medical supplies across Canada and the United States. The company operates through its e-commerce platform, leadingmedicalproducts.com, catering to both consumers and healthcare professionals.

Products and Services
  • Assistive devices for daily living and mobility aids
  • Comprehensive wound care and diabetic management products
  • Home diagnostic kits and respiratory equipment
Growth Outlook
  • Expanding inventory to meet increasing demand for home medical supplies
  • Targeting healthcare professionals and medical distributors for broader market reach
  • Plans to enhance online presence and customer engagement through digital marketing
Financial Highlights
  • Recent quarterly net income of -$10,917, indicating ongoing investment in growth
  • Trailing twelve months (TTM) revenue remains at $0, reflecting development stage
  • Current ratio of 0.79 suggests potential liquidity challenges
Health Advance Inc. is positioned in the healthcare sector, specifically within the medical and pharmaceutical industry. The company aims to address the growing need for home medical supplies, particularly as the population ages and the demand for at-home care increases. With a focus on e-commerce, Health Advance Inc. is leveraging technology to reach a wider audience, including healthcare professionals and individual consumers. Despite the challenges reflected in the financial data, including a TTM revenue of $0 and a negative net income, the company is actively investing in its growth strategy. The current ratio indicates a need for careful management of short-term liabilities, but the overall market for home medical supplies presents significant opportunities for expansion. Investors may find interest in the company's potential to capture market share in a growing industry, especially as it enhances its product offerings and online presence. The strategic focus on e-commerce and partnerships with healthcare professionals could position Health Advance Inc. for future growth in a competitive landscape.
AI Generated • Sep 9, 2026

Industry

Specialty Retail

Sector

Consumer Discretionary

Employees

2

CEO

Larry McLachlin

Website

healthadvancegroup.com

Headquarters

Las Vegas, NV 89103, US

HADV Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

55.38%

Return on Capital

-37.62%

Return on Assets

-17.29%

Earnings Yield

-50.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$312.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.56B

Volume

250.00K

Avg. Volume

6.08M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$65.41K

EBITDA

-$65.41K

Operating Cash Flow

-$56.19K

Capital Expenditure

$0.00

Free Cash Flow

-$56.19K

Cash & ST Invst.

$1.28K

Total Debt

$357.45K

Health Advance Performance Analysis

Health Advance annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 0N/A
20242024-03-31USD 0N/A
20252025-03-31USD 0N/A
20262026-03-31USD 0N/A
Health Advance sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-09-30N/A
Q22025-12-31N/A
Q32026-03-31N/A
Q42026-03-31N/A
Health Advance annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD -0.0075.0%
20242024-03-31USD -0.00-78.6%
20252025-03-31USD -0.00-66.7%
20262026-03-31USD -0.000.0%
Health Advance sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-09-30N/A
Q22025-12-31N/A
Q32026-03-31N/A
Q42026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$312.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$104.10K

N/A

Employees

3

N/A

Net Income

-$50.31K

-360.8%

EBITDA

-$30.12K

-187.2%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$1.28K

+215.0%

Total Debt

$357.45K

+18.4%

Accounts Receivable

$36.23K

+0.0%

Inventory

$0.00

N/A

Long Term Debt

$277.52K

+9.2%

Short Term Debt

$79.93K

+66.9%

Return on Assets

-17.29%

N/A

Return on Invested Capital

-69.63%

N/A

Free Cash Flow

-$5.20K

+0.2%

Operating Cash Flow

-$5.21K

-0.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMMBImmunotech Laboratories, Inc.
$0.00+0.00%
DECNDecision Diagnostics Corp.
$0.00+0.00%
SPPHSpencer Pharmaceutical Inc.
$0.00+0.00%
NNBPNanobac Pharmaceuticals, Incorporated
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.84+1.97%
INTCIntel
$97.14-0.05%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$102.32+1.18%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$51.10-1.22%

Questions About HADV

What is the current price of Health Advance?

Health Advance is trading at $0.00 per share.

What is the 52-week range for Health Advance?

Over the past 52 weeks, Health Advance has traded between $0.00 and $0.00.

How much debt does Health Advance have?

As of the most recent reporting period, Health Advance reported total debt of $351.66K.

How much cash does Health Advance have on hand?

Health Advance reported $1.30K in cash and cash equivalents in its most recent financial results.

What is Health Advance’s dividend yield?

Health Advance does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services